Loading...
Complex Royalty Structures And Drug Pricing Pressures Will Erode Long-Term Cash Flows
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
34.2%7D
-4.7%1Y
34.2%7D
-4.7%You can edit this narrative until Dec 14 7:10 PM. Then, changes will post as Updates.